Safety and efficacy of elbasvir/grazoprevir for the treatment of chronic hepatitis C: current evidence

Safety and efficacy of elbasvir/grazoprevir for the treatment of chronic hepatitis C: current evidence

Kenichi Morikawa, Akihisa Nakamura, Tomoe Shimazaki, Naoya Sakamoto Department of Gastroenterology and Hepatology, Hokkaido University Faculty of Medicine and Graduate School of Medicine, Sapporo, Japan Abstract: Treatments for hepatitis C virus (HCV) have advanced greatly, becoming more efficacio...

Full description

Bibliographic Details
Main Authors: Morikawa K, Nakamura A, Shimazaki T, Sakamoto N
Format: Article
Language:English
Published: Dove Medical Press 2018-09-01
Series:Drug Design, Development and Therapy
Subjects:
HCV
DAAs
compensated LC
HCV/HIV
CKD
Online Access:https://www.dovepress.com/safety-and-efficacy-of-elbasvir-grazoprevir-for-the-treatment-of-chron-peer-reviewed-article-DDDT

Internet

https://www.dovepress.com/safety-and-efficacy-of-elbasvir-grazoprevir-for-the-treatment-of-chron-peer-reviewed-article-DDDT

Similar Items